Viemed Healthcare (VMD) Common Equity (2018 - 2026)

Viemed Healthcare has reported Common Equity for 9 years, with the latest figure at $143.9 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity rose 5.2% year-over-year to $143.9 million; the trailing twelve-month figure through Mar 2026 stood at $143.9 million (up 5.2% YoY), and the FY2025 full-year result was $141.5 million, up 6.18% from the prior year.
• Common Equity for Q1 2026 stood at $143.9 million, up from $141.5 million in the prior quarter.
• The five-year high for Common Equity was $143.9 million in Q1 2026, with the low at $93.2 million in Q2 2022.
• Historically, Common Equity has averaged $117.9 million across 5 years, with a median of $116.3 million in 2024.
• Annual changes were most pronounced in 2022 — Common Equity advanced 2.4% — and 2025, when it advanced 17.61%.
• Viemed Healthcare's Common Equity stood at $97.1 million in 2022, then rose by 17.3% to $113.9 million in 2023, then rose by 17.04% to $133.3 million in 2024, then rose by 6.18% to $141.5 million in 2025, then climbed by 1.64% to $143.9 million in 2026.
• The last three Common Equity figures came in at $143.9 million (Q1 2026), $141.5 million (Q4 2025), and $135.5 million (Q3 2025), per Business Quant data.